The annual meeting of the American Society of Clinical Oncology (ASCO) is set to commence on June 2 in Chicago, with the highly anticipated plenary session taking place on the Sunday.
This year’s conference promises to be a landmark event with groundbreaking presentations from a number of major companies.
This year, ASCO’s leadership is focused on the theme of blending scientific advances with compassionate care to improve patient outcomes.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze